{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:30:04Z","timestamp":1792873804580,"version":"4.5.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010418","name":"Institute for Information and Communications Technology Promotion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>The complex and evolving nature of clinical phenotypes have made genetically diagnosing pediatric patients with movement disorders difficult. Here, we describe this diverse complexity in the clinical and genetic features of a pediatric cohort examined by whole-exome sequencing (WES) and demonstrate the clinical benefit of WES as a diagnostic tool in a pediatric cohort. We evaluated 75 patients with diverse single or combined movement phenomenologies using WES. WES identified 42 variants in 37 genes (56.0%). The detection rate was highest in patients with dystonia (11\/13, 84.6%), followed by ataxia (21\/38, 55.3%), myoclonus (3\/6, 50.0%), unspecified dyskinesia (1\/4, 25.0%), tremor (1\/1, 100%), respectively. Most genetically diagnosed patients (90.5%) were affected by other neurologic or systemic manifestations; congenital hypotonia (66.7%), and epilepsy (42.9%) were the most common phenotypes. The genetic diagnosis changed the clinical management for five patients (6.7%), including treatments targeting molecular abnormalities, and other systemic surveillance such as cancer screening. Early application of WES yields a high diagnostic rate in pediatric movement disorders, which can overcome the limitations of the traditional phenotype-driven strategies due to the diverse phenotypic and genetic complexity. Additionally, this early genetic diagnosis expands the patient\u2019s clinical spectrum and provides an opportunity for tailored treatment.<\/jats:p>","DOI":"10.3389\/fgene.2022.829558","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T08:00:21Z","timestamp":1654070421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Phenotypic and Genetic Complexity in Pediatric Movement Disorders"],"prefix":"10.3389","volume":"13","author":[{"given":"Min-Jee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Sun","family":"Yum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go Hun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Sung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8850708","DOI":"10.1155\/2021\/8850708","article-title":"Ataxia Telangiectasia Mutated Protein Kinase: a Potential Master Puppeteer of Oxidative Stress-Induced Metabolic Recycling","volume":"2021","author":"Blignaut","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12881-017-0436-1","article-title":"Cascade Fumarate Hydratase Mutation Screening Allows Early Detection of Kidney Tumour: a Case Report","volume":"18","author":"Chan","year":"2017","journal-title":"BMC Med. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1212\/nxg.0000000000000265","article-title":"Genetic Landscape of Pediatric Movement Disorders and Management Implications","volume":"4","author":"Cordeiro","year":"2018","journal-title":"Neurol. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/14737175.2019.1648211","article-title":"Paroxysmal Movement Disorders - Practical Update on Diagnosis and Management","volume":"19","author":"De Gusmao","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.spen.2018.01.002","article-title":"Inherited and Acquired Choreas","volume":"25","author":"de Gusmao","year":"2018","journal-title":"Seminars Pediatr. Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/mds.25933","article-title":"Paroxysmal Dyskinesias Revisited: a Review of 500 Genetically Proven Cases and a New Classification","volume":"29","author":"Erro","year":"2014","journal-title":"Mov. Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/gcc.22905","article-title":"Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Associated Uterine Smooth Muscle Tumors: Bridging Morphology and Clinical Screening","volume":"60","author":"Garg","year":"2021","journal-title":"Genes Chromosom. Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3389\/fgene.2019.01026","article-title":"Diagnostic Yield of a Targeted Next-Generation Sequencing Gene Panel for Pediatric-Onset Movement Disorders: a 3-year Cohort Study","volume":"10","author":"Graziola","year":"2019","journal-title":"Front. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/jcm9113724","article-title":"Clinical Application of Whole Exome Sequencing to Identify Rare but Remediable Neurologic Disorders","volume":"9","author":"Kim","year":"2020","journal-title":"Jcm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yebeh.2018.06.010","article-title":"The Glucose Transporter Type 1 (Glut1) Syndromes","volume":"91","author":"Koch","year":"2019","journal-title":"Epilepsy & Behav."},{"key":"B11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1055\/s-0033-1334475","article-title":"Acetazolamide-responsive Ataxia","volume":"32","author":"Kotagal","year":"2012","journal-title":"Semin. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer","volume":"19","author":"Li","year":"2017","journal-title":"J. Mol. Diagnostics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.redox.2016.12.030","article-title":"Oxidative Stress, Mitochondrial Abnormalities and Antioxidant Defense in Ataxia-Telangiectasia, Bloom Syndrome and Nijmegen Breakage Syndrome","volume":"11","author":"Maciejczyk","year":"2017","journal-title":"Redox Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1001\/jamaneurol.2018.1478","article-title":"Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders","volume":"75","author":"Montaut","year":"2018","journal-title":"JAMA Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/humu.22450","article-title":"A Post-hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases","volume":"34","author":"Neveling","year":"2013","journal-title":"Hum. Mutat."},{"key":"B16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/dmcn.14407","article-title":"The Expanding Spectrum of Movement Disorders in Genetic Epilepsies","volume":"62","author":"Papandreou","year":"2020","journal-title":"Dev. Med. Child. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1212\/con.0000000000000756","article-title":"Movement Disorders in Children","volume":"25","author":"Pearson","year":"2019","journal-title":"CONTINUUM Lifelong Learn. Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ejpn.2018.01.013","article-title":"The Relevance of Gene Panels in Movement Disorders Diagnosis: a Lab Perspective","volume":"22","author":"Reale","year":"2018","journal-title":"Eur. J. Paediatr. Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/s1474-4422(19)30033-x","article-title":"Clinical Application of Next-Generation Sequencing to the Practice of Neurology","volume":"18","author":"Rexach","year":"2019","journal-title":"Lancet Neurology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/mds.23088","article-title":"Definition and Classification of Hyperkinetic Movements in Childhood","volume":"25","author":"Sanger","year":"2010","journal-title":"Mov. Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/cge.13848","article-title":"Diagnostic Yield and Clinical Utility of Whole Exome Sequencing Using an Automated Variant Prioritization System, EVIDENCE","volume":"98","author":"Seo","year":"2020","journal-title":"Clin. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10020-022-00464-x","article-title":"Diagnostic Performance of Automated, Streamlined, Daily Updated Exome Analysis in Patients with Neurodevelopmental Delay","volume":"28","author":"Seo","year":"2022","journal-title":"Mol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/mds.26937","article-title":"A Post Hoc Study on Gene Panel Analysis for the Diagnosis of Dystonia","volume":"32","author":"van Egmond","year":"2017","journal-title":"Mov. Disord."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.829558\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T08:00:26Z","timestamp":1654070426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.829558\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":23,"alternative-id":["10.3389\/fgene.2022.829558"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.829558","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"article-number":"829558"}}